期刊文献+

QRS时限对左心室导线电延迟与心脏再同步治疗长期疗效相关性的影响 被引量:2

Impact of QRS duration on the relationship between left ventricle lead electrical delay and clinical response after cardiac resynchronization therapy
原文传递
导出
摘要 目的 探讨QRS时限是否影响左心室导线电延迟(LVLED)与心脏再同步治疗(CRT)长期疗效的相关性.方法 前瞻性入选2011年10月至2013年3月在阜外心血管病医院成功植入CRT患者,在围术期测量Q波起始到左心室导线感知波最高峰的时间间距(QLV)反映LVLED.根据患者基线QRS时限分为宽QRS组(≥150 ms)和窄QRS组(<150 ms),基线及术后定期检查超声心动图及随访情况.CRT有反应定义为术后最后1次随访时左心室射血分数提高≥0.05.结果 共入选93例患者,81例患者完成(15±3)个月的随访.平均年龄(60.1±10.4)岁,72%为左束支阻滞,80%为非缺血性心肌病,37.0%为女性.宽QRS组61例,窄QRS组20例.宽QRS组的QLV显著长于窄QRS组[(109.9±38.1) ms对(77.5±37.6) ms,P<0.05].整体CRT有反应率为66.7%.宽QRS组CRT有反应率显著高于窄QRS组(72.1%对50%,P<0.05).在宽QRS组,CRT有反应率随QLV四分位分组显著增加(57.0%,73.3%,80.0%,87.5%,P=0.017).但窄QRS组QLV四分位组间CRT有反应率差异无统计学意义(P>0.05).多因素回归分析校正年龄、性别、束支阻滞和缺血性心肌病后,宽QRS组长QLV与CRT有反应显著相关(OR4.12,95% CI 2.17~8.68,P=0.012).但窄QRS组QLV与CRT反应无相关性(P>0.05).结论 只有当基线QRS时限≥150 ms时,应用LVLED指导左心室导线位置有助于提高CRT的长期疗效. Objective The left ventricle lead electrical delay (LVLED)has been associated with reverse remodeling after cardiac resynchronization therapy(CRT).The impact of QRS duration on the relationship between LVLED and CRT clinical response remains unclear.Methods We prospectively enrolled a series of consecutive patients undergoing CRT implantation according to standard clinical indications.The LVLED was measured from the onset of the surface electrco cardiogram QRS complex to the first large peak of the unipolar LV tip to can intracardiac electrogram during spontaneous rhythm via the programmer,which is also called QLV.Patients were devided into with wide or with narrow QRS groups according to the QRS duration(≥or〈150 ms).Echocardiograms were assessed at baseline and follow-up interviews after CRT implantation.CRT response was defined as an absolute improvement in LV ejection fraction of ≥5 percentage points after CRT.Results A total of 93 patients entered into this study,and 81 patients [mean age(60.1 ± 10.4)years,72% of the patients had left bundle-branch block morphology,80% of the patients had non-ischemia cardiomyopathy,37.5% female,mean QRS interval (165.1 ± 22.5 ms)] finished a mean follow-up of (15 ±3) months.Patients with wide QRS had longer QLV intervals [(109.9±38.1) ms vs.(77.5±37.6) ms,P〈0.05] and more CRT responders(70.8% vs.50%,P〈0.05) than patients with narrow QRS (total of 66.7% responders of CRT).In patients with wide QRS,CRT responders increased progressively from 50.0% to 88.4% when separated by quartiles based on QLV interval(P 〈0.05).However,no relationship was found between QLV intervals and CRT response(P〉0.05) in patients with narrow QRS.After adjustment for age,sex,bundle-branch block,and ischemia cardiomyopathy by multivariate logistic regression analysis,the relationship between QLV intervals and CRT response was still significant in patients with wide QRS (OR:4.12,95% CI:2.17 to 8.68,P =0.012),but not in patients with narrow QRS (P〉 0.05).Conclusions LVLED is strongly associated with improvement in LV ejection fraction after CRT only in patients with QRS ≥ 150 ms,but not in patients with QRS〈 150 ms.Impact of QRS duration should be considered when LVLED is used to predict CRT clinical response.
出处 《中华心律失常学杂志》 2014年第6期439-443,共5页 Chinese Journal of Cardiac Arrhythmias
关键词 左心室导线电延迟 心脏再同步治疗 QRS时限 心室重构 Left ventricle lead electrical delay Cardiac resynchronization therapy QRS duration Ventricular remodeling
  • 相关文献

参考文献22

  • 1Abraham WT, Fisher WG, Smith AL,et al.Cardiac resynchronization in chronic heart failure[J].N Engl J Med,2002,346:1845-1853.
  • 2Bleeker GB, Bax JJ, Fung JWH, et al. Clinical versus echocardio- graphic parameters to assess response to cardiac resynchronization therapy [ J ].Am J Cardio1,2006,97 : 260- 263.
  • 3Bax J J, Bleeker GB, Marwick TH, et al.Left ventricular dyssynchro- ny predicts response and prognosis after cardiac resynchronization therapy[ J].J Am Coil Cardiol,2004,44:1834-1840.
  • 4Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization thera- py :The Task Force on eardiacpaeing and resynchronization therapy of the European Society of Cardiology(ESC) [ J ] .Europaee, 2013, 15 : 1070-1118.
  • 5Gold MR, Birgersdotter-Green U, Singh JP, et al.The relationship between ventrieular electrical delay and left ventricular remodelling with cardiac resynchronization therapy [ J ]. Eur Heart J, 2011,32 : 2516- 2524.
  • 6Stavrakis S, Lazzara R, Thadani U.The benefit of cardiac resynchro- nization therapy and QRS duration: a meta-analysis [ J ].J Cardio- vasc Electrophysio1,2012,23 : 163-168.
  • 7Bax JJ, Marwick TH, Molhoek SG, et al. Left ventricular dyssyn- chrony predicts benefit of cardiac resynchronization therapy in pa- tients with end-stage heart failure before pacemaker implantation [ J] .Am J Cardiol,2003,92:1238-1240.
  • 8Dickstein K,Cohen-Solal A,Filippatos G,et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology [ J] .Eur Heart J,2008,29:2388-2442.
  • 9Dickstein K,Vardas PE, Auricchio A, et al.2010 focused update of ESC Guidelines on device therapy in heart failure : an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy [ J ]. Eur J Heart Fail, 2010, 12: 1143- 1153.
  • 10McMurray JJ, Adamopoulos S, Anker SD, et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012:The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardi- ology[ J] .Ear Heart J,2012,33 : 1787-1847.

二级参考文献9

  • 1HUA Wei NIU Hong-xia WANG Fang-zheng ZHANG Shu CHEN Ke-ping CHEN Xin.Short-term effect of cardiac resynchronization therapy in patients with ischaemic or nonischaemic cardiomyopathy[J].Chinese Medical Journal,2006(18):1507-1510. 被引量:5
  • 2Antonio N,Teixeira R,Coelho L,et al.Identification of 'super-responders' to cardiac resynchronization therapy:the importance of symptom duration and left ventricular geometry.Europace,2009,11:343-349.
  • 3van Bommel RJ,Bax JJ,Abraham WT,et al.Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy:a PROPSECT sub-analysis.Eur Heart J,2009,30:2470 -2477.
  • 4Rickard J,Kumbhani DJ,Popovic Z,et al.Characterization of super-response to cardiac resynchronization therapy.Heart Rhythm,2010,7:885-889.
  • 5Sabbah HN,Sharov VG,Lesch M,et al.Progression of heart failure:a role for interstitial fibrosis.Mol Cell Biochem,1995,147:29-34.
  • 6Gürtl B,Kratky D,Guelly C,et al.Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy.Int J Exp Pathol,2009,90:338-346.
  • 7Kamireddy S,Agarwal SK,Adelstein E,et al.Correlation of electrical and mechanical reverse remodeling after cardiac resynchronization therapy.Ann Noninvasive Electrocardiol,2009,14:153-157.
  • 8杨新春,陈新.心脏再同步治疗心力衰竭的机制[J].中华心律失常学杂志,2009,13(1):7-8. 被引量:7
  • 9丁立刚,华伟.心力衰竭合并右束支传导阻滞患者心脏再同步化治疗现状[J].中国心脏起搏与心电生理杂志,2009,23(4):294-296. 被引量:7

共引文献9

同被引文献19

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部